1. Protein Biomarkers and Major Cardiovascular Events in Older People With Advanced CKD: The European Quality (EQUAL) Study
- Author
-
Samantha J.L. Hayward, Nicholas C. Chesnaye, Barnaby Hole, Ryan Aylward, Yvette Meuleman, Claudia Torino, Gaetana Porto, Maciej Szymczak, Christiane Drechsler, Friedo W. Dekker, Marie Evans, Kitty J. Jager, Christoph Wanner, and Fergus J. Caskey, MD
- Subjects
Biomarker ,cardiovascular disease ,chronic kidney disease ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Rationale & Objective: Cardiovascular disease is the leading cause of morbidity and mortality in chronic kidney disease (CKD). We investigated 184 inflammatory and cardiovascular proteins to determine their potential as biomarkers for major cardiovascular events (MACEs). Study Design: The European Quality (EQUAL) is an observational cohort study that enrolled people aged ≥65 years with an estimated glomerular filtration rate ≤20 mL/min/1.73 m2. Setting & Participants: Recruited participants were split into the discovery (n = 611) and replication cohorts (n = 292). Exposure: Levels of 184 blood proteins were measured at the baseline visit, and each protein was analyzed individually. Outcome: MACE. Analytical Approach: Cox proportional hazard models adjusted for age, sex, estimated glomerular filtration rate, previous MACE, and country were used to determine the risk of MACE. Proteins with false discovery rate adjusted P values of
- Published
- 2024
- Full Text
- View/download PDF